STXS
StereotaxisยทAMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
STXS Profile
Stereotaxis, Inc.
A pioneer and global leader in surgical robotics for minimally invasive endovascular intervention
Healthcare Equipment and Supplies
--
09/06/2019
American Stock Exchange
139
12-31
Common stock
710 North Tucker Boulevard, Suite 110, St. Louis, MO 63101
--
Stereotaxis, Inc., was incorporated in Delaware in June 1990. The company is a pioneer and global leader in the field of minimally invasive endovascular interventional surgical robots. The company designs, manufactures and sells robotic systems, instruments and information systems for interventional laboratories. The company's proprietary robotics technology, robotic magnetic navigation, fundamentally alters endovascular intervention, using precise computer-controlled magnetic fields to directly control the tip of a flexible interventional catheter or device. Directly controlling the tip of the intervention device, unlike all manual handheld devices controlled from the handle, improves the accuracy, stability, antennae and safety of these devices during operation. The company's primary clinical focus has been electrophysiology, specifically cardiac ablation surgery for the treatment of arrhythmias.
